University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which ...

Researchers from the Cluster of Excellence Balance of the Microverse at the University of Jena and the Leibniz-HKI, together with international partners, have uncovered a mechanism that determines how ...

Resistance to initial therapy sets the stage for many other options ...

That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...

University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which a single chromosome is shattered into pieces and rearranged in a scrambled ...

Researchers from CIIMAR and the University of Helsinki have discovered a new biochemical modification in natural cyanobacterial products, revealing an unprecedented tool with promising applications in ...

Nobel laureate David Baker’s latest foundation model can design proteins that interact to any biomolecule for broad biotech applications.

Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), a spectrum of liver conditions ranging from simple ...

Discover why Eli Lilly and Company's retatrutide weight loss breakthrough positions LLY as a leader in obesity therapeutics.

Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...

Novel weapons to counter endocrine therapy resistance and treat progressive disease ...